ADGI Insider Trading

96.94% of Adagio Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adagio Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/24/2022	Prelude Capital Management LLC	21,800	$72K	0.0%	N/A	0.020%
8/18/2022	Goldman Sachs Group Inc.	412,564	$1.35M	0.0%	+976.5%	0.376%
8/16/2022	Woodline Partners LP	198,962	$0.65M	0.0%	N/A	0.181%
8/16/2022	Price T Rowe Associates Inc. MD	520,949	$1.71M	0.0%	+4.0%	0.475%
8/15/2022	State Street Corp	935,152	$3.07M	0.0%	+29.7%	0.852%
8/15/2022	Millennium Management LLC	95,499	$0.31M	0.0%	N/A	0.087%
8/13/2022	American International Group Inc.	24,027	$79K	0.0%	-17.8%	0.022%
8/12/2022	Northern Trust Corp	371,727	$1.22M	0.0%	-13.2%	0.339%
8/12/2022	Virtus ETF Advisers LLC	39,281	$0.13M	0.0%	+83.9%	0.036%
8/12/2022	Rhumbline Advisers	75,683	$0.25M	0.0%	+41.9%	0.069%
8/11/2022	Alps Advisors Inc.	65,095	$0.21M	0.0%	N/A	0.059%
8/11/2022	JPMorgan Chase & Co.	353,053	$1.16M	0.0%	-3.6%	0.322%
7/29/2022	SG Americas Securities LLC	18,080	$59K	0.0%	N/A	0.016%
7/20/2022	Clear Harbor Asset Management LLC	14,500	$48K	0.0%	N/A	0.013%
6/7/2022	Bank of America Corp DE	41,979	$0.19M	0.0%	-83.1%	0.038%
5/17/2022	Point72 Hong Kong Ltd	12,026	$55K	0.0%	N/A	0.011%
5/16/2022	California State Teachers Retirement System	25,195	$0.12M	0.0%	+120.8%	0.023%
5/16/2022	Goldman Sachs Group Inc.	38,323	$0.18M	0.0%	+66.7%	0.035%
5/16/2022	PDT Partners LLC	35,188	$0.16M	0.0%	+15.9%	0.032%
5/16/2022	Third Point LLC	987,114	$4.50M	0.1%	N/A	0.900%
5/16/2022	State Street Corp	721,192	$3.29M	0.0%	-55.6%	0.658%
5/16/2022	UBS Group AG	11,883	$54K	0.0%	-87.6%	0.011%
5/13/2022	Northern Trust Corp	428,159	$1.95M	0.0%	+130.4%	0.390%
5/13/2022	Charles Schwab Investment Management Inc.	208,989	$0.95M	0.0%	+51.7%	0.191%
5/13/2022	American International Group Inc.	29,230	$0.13M	0.0%	+160.4%	0.027%
5/13/2022	Vanguard Group Inc.	5,324,126	$24.28M	0.0%	+247.1%	4.854%
5/13/2022	M28 Capital Management LP	6,398,250	$29.18M	26.8%	+12.9%	5.834%
5/12/2022	BlackRock Inc.	2,951,595	$13.46M	0.0%	+125.8%	2.691%
5/12/2022	Rhumbline Advisers	53,319	$0.24M	0.0%	+133.3%	0.049%
5/12/2022	MetLife Investment Management LLC	38,979	$0.18M	0.0%	+403.6%	0.036%
5/12/2022	Artal Group S.A.	1,000,000	$4.56M	0.2%	N/A	0.912%
5/12/2022	Citigroup Inc.	25,304	$0.12M	0.0%	-73.6%	0.023%
5/11/2022	Bank of New York Mellon Corp	174,158	$0.79M	0.0%	+157.1%	0.159%
5/11/2022	JPMorgan Chase & Co.	366,392	$1.67M	0.0%	+2,707.4%	0.334%
5/11/2022	GSA Capital Partners LLP	21,505	$98K	0.0%	N/A	0.020%
5/10/2022	ProShare Advisors LLC	11,037	$51K	0.0%	N/A	0.010%
5/5/2022	New York State Common Retirement Fund	30,864	$0.14M	0.0%	+106.3%	0.028%
5/4/2022	Advisor Group Holdings Inc.	7,500	$34K	0.0%	N/A	0.007%
4/21/2022	Strs Ohio	13,900	$63K	0.0%	+189.6%	0.013%
2/15/2022	Slate Path Capital LP	3,735,000	$27.12M	1.4%	N/A	3.357%
2/15/2022	Adage Capital Partners GP L.L.C.	15,000	$0.11M	0.0%	N/A	0.013%
2/15/2022	683 Capital Management LLC	620,000	$4.50M	0.2%	N/A	0.557%
2/14/2022	PDT Partners LLC	30,356	$0.22M	0.0%	N/A	0.027%
2/14/2022	Virtus ETF Advisers LLC	22,625	$0.16M	0.1%	N/A	0.020%
2/14/2022	Redmile Group LLC	1,920,960	$13.95M	0.3%	-40.8%	1.727%
2/14/2022	ETF Managers Group LLC	33,598	$0.26M	0.0%	-28.3%	0.030%
2/11/2022	Parkwood LLC	34,461	$0.25M	0.0%	N/A	0.031%
2/11/2022	M28 Capital Management LP	5,665,221	$41.13M	32.1%	N/A	5.092%
2/10/2022	Rafferty Asset Management LLC	122,644	$0.89M	0.0%	N/A	0.110%
2/10/2022	TD Asset Management Inc.	31,300	$0.23M	0.0%	N/A	0.028%
2/10/2022	Rathbones Group PLC	10,000	$73K	0.0%	N/A	0.009%
2/2/2022	New York State Common Retirement Fund	14,964	$0.11M	0.0%	+39.9%	0.013%
1/28/2022	Allspring Global Investments Holdings LLC	7,608	$55K	0.0%	N/A	0.007%
1/26/2022	Hellman Jordan Management Co. Inc. MA	10,000	$73K	0.1%	N/A	0.009%
11/17/2021	ArrowMark Colorado Holdings LLC	2,772,927	$117.13M	0.9%	N/A	2.492%
11/16/2021	Two Sigma Investments LP	23,713	$1M	0.0%	N/A	0.021%
11/16/2021	Metropolitan Life Insurance Co NY	5,856	$0.25M	0.0%	N/A	0.005%
11/16/2021	Bain Capital Life Sciences Investors LLC	2,487,207	$105.06M	6.5%	N/A	2.236%
11/15/2021	California State Teachers Retirement System	11,414	$0.48M	0.0%	N/A	0.010%
11/15/2021	RA Capital Management L.P.	5,340,130	$225.57M	3.1%	N/A	4.800%
11/15/2021	Voya Investment Management LLC	8,181	$0.35M	0.0%	N/A	0.007%
11/15/2021	Caas Capital Management LP	40,000	$1.69M	0.0%	N/A	0.036%
11/15/2021	Ensign Peak Advisors Inc	113,183	$4.78M	0.0%	N/A	0.102%
11/15/2021	Franklin Resources Inc.	500,014	$21.12M	0.0%	N/A	0.449%
11/15/2021	Foresite Capital Management V LLC	1,280,640	$54.09M	16.8%	N/A	1.151%
11/12/2021	Ghisallo Capital Management LLC	40,000	$1.69M	0.1%	N/A	0.036%
11/12/2021	The Manufacturers Life Insurance Company	11,729	$0.50M	0.0%	N/A	0.011%
11/12/2021	Geode Capital Management LLC	372,031	$15.71M	0.0%	N/A	0.334%
11/12/2021	EAM Investors LLC	29,289	$1.24M	0.2%	N/A	0.026%
11/10/2021	Citigroup Inc.	2,496	$0.11M	0.0%	N/A	0.002%
11/10/2021	Alliancebernstein L.P.	21,500	$0.91M	0.0%	N/A	0.019%
11/9/2021	BlackRock Inc.	1,329,055	$56.14M	0.0%	N/A	1.195%
11/5/2021	Lindbrook Capital LLC	800	$34K	0.0%	N/A	0.001%
11/4/2021	Deutsche Bank AG	12,652	$0.53M	0.0%	N/A	0.011%
11/2/2021	New York State Common Retirement Fund	10,700	$0.45M	0.0%	N/A	0.010%
11/2/2021	Inverness Counsel LLC NY	12,000	$0.51M	0.0%	N/A	0.011%
11/1/2021	SG Americas Securities LLC	9,500	$0.40M	0.0%	N/A	0.009%
10/28/2021	M&T Bank Corp	10,320	$0.44M	0.0%	N/A	0.009%
10/22/2021	Strs Ohio	4,800	$0.20M	0.0%	N/A	0.004%

Data available starting January 2016

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

Today's Range

Now: N/A

50 Day Range

MA: $4.21

$3.40

$4.78

52 Week Range

Now: N/A

Volume

22,357 shs

Average Volume

2,269,922 shs

Market Capitalization

$504.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Adagio Therapeutics?: Adagio Therapeutics' top insider shareholders include:
Marc Elia (Director)
Learn More about top insider investors at Adagio Therapeutics.